DCF — AVERA MARSHALL REGIONAL MEDICAL CTR
Enterprise Value: $-295.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-295.0M
Enterprise Value
$-91.1M
PV of Cash Flows
$-203.9M
PV of Terminal Value
$-328.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $118.7M | $-19.6M | -17.0% | $-24.6M | $-22.4M |
| Year 2 | $122.3M | $-19.0M | -16.0% | $-24.1M | $-19.9M |
| Year 3 | $125.9M | $-18.3M | -15.0% | $-23.6M | $-17.7M |
| Year 4 | $129.7M | $-18.2M | -14.0% | $-23.7M | $-16.2M |
| Year 5 | $133.6M | $-18.4M | -14.0% | $-24.0M | $-14.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-295.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$115.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17003382619525365
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5